(2004). Is major depressive disorder or dys- thymia more strongly associated with bulimia nervosa? International Journal of Eating Disorders, 36, 55-61.Perez M, Joiner TE, Lewinsohn PM. Is major depressive disorder or dysthymia more strongly associated with bulimia nervosa? International Journal ...
Coherence of neural activity, or functional connectivity, within the brain's DMN is increased in major depressive disorder relative to healthy control (HC) subjects; however, whether similar abnormalities are present in persons with dysthymic disorder (DD) is unknown. Moreover, the effect of ...
Amisulpride versus imipramine and placebo in dysthymia and major depression Amisulpride, a selective antagonist of D-2 and D-3 dopamine receptors, acts preferentially on presynaptic receptors increasing dopaminergic transmission at... Y Lecrubier,P Boyer,S Turjanski,... - 《Journal of Affective Dis...
Bupropion versus trazodone Bupropion and its metabolites Bupropion (Wellbutrin) vs SSRIs Bupropion for depressed bipolars Bupropion used to augment SSRIs Bupropion versus methylphenidate Bupropion and the dopamine transporter Bupropion for major depressive disorder (MDD) Bupropion: pharmacology and therapeutic ...
Dysthymia is a depressive disorder of chronic nature but of lower severity than major depression. Depressive symptoms are more or less continuous for at least two years. Patients with this disorder experience considerable social dysfunction and disability and are more likely than the general population...
OBJECTIVE: The authors sought to determine the efficacy of antidepressants in dysthymic disorder and to compare antidepressant and placebo response rates between major depressive disorder (MDD) and dysthymic disorder. DATA SOURCES: PubMed/MEDLINE databases were searched for double-blind, randomized, ...
OBJECTIVES: Dysthymia is a depressive disorder of chronic nature but of less severity than major depression, which depressive symptoms are more or less continuous for at least two years. The aim of this review was to conduct a systematic review of all RCTs comparing drugs and placebo for ...
European NeuropsychopharmacologyAlby JM, Cabane J, Ferreri M, Bougerol T. Efficacy and acceptability of tianeptine in major depressive disorder and in dysthymia (DSM-III-R) with somatic complaints: double-blind study versus fluoxetine. Eur Ann Psychiatry 1993;8:136-144....
In a multicentre, 6 months, placebo-controlled trial, amisulpride (50 mg/daily) was compared to imipramine (100 mg/daily) in the treatment of patients with DSM-III-R criteria for primary dysthymia, dysthymia with major depression or major depression in partial remission. A total of 219 ...
Drugs versus placebo for dysthymia - Lima, Moncrieff - 2002 () Citation Context ...isorder and that has lasted without any period of remission for at least 2 years). Here, antidepressants appear to have an advantage over placebo to the same degree as with major depressive disorder (=-=...